Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions

Cavarra, Mauro, Falzone, Alessandra, Ramaekers, Johannes G., Kuypers, Kim P. C., Mento, Carmela·2022·Frontiers in Psychology
DOI 10.3389/fpsyg.2022.887255

Cited by (171)

Items 101–171 of 171

  1. Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy
    Yves Martins Varela, Patrícia Cavalcanti-Ribeiro, Geovan Menezes de Sousa, Marcelo Falchi-Carvalho, Juliana dos santos fernandes Barbalho, Rayanara Bolcont de Oliveira Gomes, Melanie Moura Medina Gurgel, Bruno Carvalho Pereira, Pamela Milena de Lima Souza, Kaike Thiê da Costa Gonçalves et al. · 2026 · Journal of Affective Disorders
  2. Psychedelic Healing: A Historical, Empirical, and Personal Account
    Robert Swoap · 2023 · American Journal of Health Promotion
  3. 3, 4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy: what the pharmacist needs to know
    Alexander T. Gallo, Paul Bernard Fitzgerald · 2024 · Journal of Pharmacy Practice and Research
  4. Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada
    K S Kim, Abban Yusuf, Abhimanyu Sud, Nav Persaud, Abirami Kirubarajan, Monique Moller, Taryn Lloyd, Braden Gregory O’Neill · 2024 · PLoS ONE
  5. Psychedelic-assisted grief therapy: a mixed-method case study
    Pablo Sabucedo, Chris Evans, Donald Nicolson, Magı́ Farré, Débora González · 2024 · Mortality
  6. Evidence-Based Therapy Models in a New Age of Psychedelic-Assisted Psychotherapy
    Adith V. Ram, Katherine L. Abraham, Eric A. Storch · 2025 · Journal of Cognitive Psychotherapy
  7. Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review
    Jennifer L. Bires · 2025 · Journal of Psychosocial Oncology
  8. Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics, Spirituality, and the Sacred: Commentary on Griffiths et al. (2025)
    Roman Palitsky, George H. Grant · 2025 · Psychedelic Medicine
  9. Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach
    Rosalind G. McAlpine, Katarina Krajnović, Maisha M. Khan, Larisa Morometescu, Otto Simonsson, Matthew D. Sacchet, Sunjeev K. Kamboj · 2023
  10. Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial
    Laetitia Vanderijst, Felix Hever, Anne Buot, Charles Dauré, Janaïna Benoit, Catherine Hanak, Johannes Veeser, Margot Morgiève, Salvatore Campanella, Charles Kornreich et al. · 2024 · Research Square
  11. Psychedelics in psychiatry
    RAFAEL GUIMARÃES DOS SANTOS, Jaime E. C. Hallak · 2024 · Elsevier eBooks
  12. A Primer for Culturally Attuned Psychedelic Research
    Terence H. W. Ching · 2024 · PsyArXiv (OSF Preprints)
  13. The Conceptual Framework for the Therapeutic Approach used in Phase 3 Trials of MDMA-AT for PTSD
    Kelley C. O’Donnell, Michael Alpert, Lauren Okano, Christopher R. N. Nicholas, Chantelle Thomas, Bruce Poulter, Ann T. Mithoefer, Michael C. Mithoefer, Marcela Ot’alora G. · 2024
  14. "Vine of the Soul": The Potential of Ayahuasca for Reducing Depression, Anxiety, and Stress among Ceremony Participants and the Role of Rumination
    Banan Ramarushton · 2024 · University of North Texas Digital Library (University of North Texas)
  15. The Birth of the Psychedelic Industry: Capitalizing on the Psychedelic Renaissance
    Minsu Yoo, Sofia Sakopoulos · 2024
  16. Reading the crowd: attitudes toward psychedelics and psychedelic therapies among attendees at a conference
    Zachary Bosshardt, Jessica L. Maples‐Keller, Deanna M. Kaplan, BARBARA OLASOV ROTHBAUM, Sarah Eisenacher, Kim Dupree Jones, Tanja Mletzko, George H. Grant, Boadie Waid Dunlop, Ali John Zarrabi et al. · 2024 · Psychedelics.
  17. The double-edged sword: Psychedelic-assisted therapy and entrepreneurial well-being, an early conceptual framework
    Pankaj C. Patel, Marcus T. Wolfe · 2025 · Journal of Business Venturing Insights
  18. Altered States of Consciousness Through Hci: Inspiration from Decades of Science Fiction
    Anatolii Belousov, Joseph Macey, Mila Bujić, Terho Ojell-Järventausta, Juho Hamari · 2025 · SSRN Electronic Journal
  19. Psychedelics’ Intoxicating Impact and Behavioural Dynamics
    Afshan Zeeshan Wasti · 2025 · Pharmaceutical science.
  20. The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives
    Shadan Rahmani, Rachel Crupi, Anthony Lee Riley, Terry L. Davidson · 2025 · Pharmacology Biochemistry and Behavior
  21. Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample
    Dan Petrovitch, Samuel Hosford, Andrew K. Littlefield, Heather Austin-Robillard · 2025 · Drug Science Policy and Law
  22. The shape of things to come-psychedelic assisted therapy and the role of the mental health nurse
    Carolyn Maile · 2025 · Archives of Psychiatric Nursing
  23. Integrating the Gestalt Model of Self With Psychedelic‐Assisted Psychotherapy
    Travis R. Fox · 2025 · The Journal of Humanistic Counseling
  24. Additional file 3 of LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
    Dimitri Daldegan‐Bueno, Carina Joy Donegan, Anna Forsyth, Rachael L. Sumner, Robin J. Murphy, David Benjamin Menkes, William James Evans, Nicholas R. Hoeh, Frederick Sundram, Lisa Reynolds et al. · 2024 · Figshare
  25. Additional file 2 of LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
    Dimitri Daldegan‐Bueno, Carina Joy Donegan, Anna Forsyth, Rachael L. Sumner, Robin J. Murphy, David Benjamin Menkes, William James Evans, Nicholas R. Hoeh, Frederick Sundram, Lisa Reynolds et al. · 2024 · Figshare
  26. Additional file 1 of LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
    Dimitri Daldegan‐Bueno, Carina Joy Donegan, Anna Forsyth, Rachael L. Sumner, Robin J. Murphy, David Benjamin Menkes, William James Evans, Nicholas R. Hoeh, Frederick Sundram, Lisa Reynolds et al. · 2024 · Figshare
  27. Innovative Pharmacological Approaches to Eating Disorder Treatment
    Aaron R. Keshen, Stephen William Touyz, Emilie Lacroix, Phillipa Hay, Susan L. McElroy · 2025 · Psychiatric Clinics of North America
  28. A qualitative analysis of participant expectations and experiences of psilocybin‐assisted psychotherapy for methamphetamine use disorder
    Jonathan Brett, Toby Lea, Elizabeth Knock, Steven M. Albert, Liam S. Acheson, Krista J. Siefried, Sebastian Job · 2025 · Addiction
  29. Ketamine Combined With Psychotherapy as a Treatment for Resistant Depression in a Public European Hospital
    Filipa Alves da Silva, Rita Silva Avelar, Bernardo Peixoto, Leonor Bacelar–Nicolau, Francisco Santos, João Costa Ribeiro, Maria João Heitor · 2026 · Brain and Behavior
  30. Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compounds
    Benjamin R. Lewis, M. Carrington Reid, Andrew M. Novick, Kevin Byrne, Mark J. Niciu, Gregory A. Fonzo, Thomas Daniel Meyer, David Feifel, Rif S. El‐Mallakh, Jair Soares et al. · 2026 · Journal of Psychopharmacology
  31. Beyond therapist competence: Why family engagement matters in real-world psychedelic services
    Bela Janare Putra, Rohmiati · 2026 · General Hospital Psychiatry
  32. Neuroinflammation, the gut-brain axis, and psychedelic-assisted psychotherapy: A synthesis of emerging paradigms in psychiatric care
    Anita Verma, Ravisankar Thamilarasan, Harshit Kumar · 2026 · Future Health
  33. It’s all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial
    Fiona Cottam, Alesha Wells, Cerys Clayden, Lisa Reynolds · 2026 · Palliative & Supportive Care
  34. A Blueprint for Implementing Ketamine-Assisted Psychotherapy in Palliative Care: Design, Process, and Treatment Patterns of a Real-World Clinical Program
    Robert K. Horowitz, William E. Rosa, Ali John Zarrabi, Marc T. Swogger · 2026 · Journal of Palliative Medicine
  35. Transient or transformative? Psychedelics, agency and informed consent
    Chiara Caporuscio · 2026 · Journal of Medical Ethics
  36. Psychedelics; an untapped therapeutic niche: a narrative review in the future of cancer pain management
    Maxine Min Chien Yap, Yasir Marwan Abdalla Omer, Yu Xuan Cheng, Wei Qi Chan, Satoshi Ogawa · 2026 · Medicine in Drug Discovery
  37. Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes
    Jonathan Stellmacher, Christopher Schmidt, Helena Aicher, Kae Eichel, Eva‐Lotta Brakemeier, Uwe Herwig · 2026 · Frontiers in Psychiatry
  38. Integrating consciousness, culture, and clinical practice: A comprehensive review of modern psychedelic research
    Asif Raihan · 2026 · Journal of Behavioral and Cognitive Therapy
  39. Psychedelics and Autism Therapy: A Review of Current Research and Future Directions
    Christopher S. Gondi, Manu Gnanamony, Tarun P. Gondi, Lilyt Nersesyan, Lusine H. Demirkhanyan · 2026 · Current Issues in Molecular Biology
  40. Ritual in Psychedelic Therapy: A Principle-Based Framework
    Shannon Dames, Grace Scharf, Vivian W. L. Tsang, Crosbie Watler, Michelle Brewer, Julia Sheffield, Pamela Kryskow · 2026 · Human Arenas
  41. Anything that helps: cancer patient and carer perspectives on psychedelic-assisted therapy
    A. Wech, Amelia Akroyd, C. Clayden, L. M. Reynolds · 2026 · Supportive Care in Cancer
  42. Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care
    Jamarie A. Geller, Rachel M. Pacilio, Amanda E. Downey, Anya Ragnhildstveit, Marissa Raymond‐Flesch, Stephanie Knatz-Peck, Natalie Gukasyan · 2026 · Current Psychiatry Reports
  43. Devaluation and Revaluation as Dynamic Social Processes: The Case of Psychedelic Stigma
    Hannah R. Farrimond, Mike Michael · 2026 · Sociology of Health & Illness
  44. Insight to Action: The Role of Occupational Therapy in Psychedelic Integration
    Gal Elkaiam, Heather Thomas, Brett Buford · 2026 · Occupational Therapy in Mental Health
  45. Preliminary Non-Randomized Clinical Trial of Subcutaneous Esketamine in Treatment-Resistant Depression: Exploring Adjunctive Effects of Ketamine-Assisted Psychotherapy
    Yves Martins Varela, Patrícia Cavalcanti Ribeiro, Geovan Menezes de Sousa, Marcelo Falchi-Carvalho, Juliana dos santos fernandes Barbalho, Rayanara Bolcont de Oliveira Gomes, Melanie Moura Medina Gurgel, Bruno Carvalho Pereira, Pamela Milena de Lima Souza, Kaike Thiê da Costa Gonçalves et al. · 2026 · medRxiv
  46. Approaches to ketamine-assisted couple therapy
    David O. Avruch · 2026 · Frontiers in Psychology
  47. Psychedelic-Assisted Psychotherapy for the Treatment of PTSD: A Systematic Review and Meta-Analysis
    Fizza Mitter, Anton Sheptooha, Janni Leung, Sarangan Ketheesan, Wọlé Akóṣílè · 2026 · Psychoactives
  48. Ketamine-Assisted Psychotherapy for Depression: A Survey of Current Practices, Rationales, and Future Directions
    Jack Buchanan, Brandon M. Reynante, Michael T. Dinh, Joseph A. Zamaria · 2026 · Journal of Psychoactive Drugs
  49. Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction
    Nadav Liam Modlin, Zsofia Elek, Carolina Maggio, Manish Agrawal, Lauren Lepow, James Rucker, Joanne Stubley, Jeffrey R. Guss · 2026 · Psychodynamic Psychiatry
  50. The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review
    Flavia Giaffone de Paiva Ferreira, João Ariel Bonar Fernandes, Renato Filev, Dartiu Xavier da Silveira, Thiago Marques Fidalgo · 2026 · Journal of Psychopharmacology
  51. Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations
    Cielo Amelia Estela-Fernandez, Reem Mohamed Yousif Elsheikh, D F Beatrice, Abdullah A. Alhendal, Chinonso Irene Ewe, Sebastian Y. Montesinos, Jocelyn Wensel, Anushka P Mishra, Asma Ahmed Yousif, Hossam Tharwat Ali · 2026 · Neuropsychiatrie
  52. Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions
    Elena Koning, Jérémie Richard, Aaron R. Keshen · 2026 · International Journal of Eating Disorders
  53. Beyond access: The SIGNAL model of internal guidance in psychedelic preparation and integration
    Stacy Rush · 2026 · Psychedelics
  54. Mechanisms of Action and Change in Psychedelic-Assisted Therapies: A Holistic Framework for Ethical, Competent Clinical Care
    Lynnette A. Averill, Logan Neitzke‐Spruill · 2026 · FOCUS The Journal of Lifelong Learning in Psychiatry
  55. Dissociation and antidepressant response to subcutaneous esketamine: A clinical study
    Kaike Thiê da Costa Gonçalves, Vagner Deuel de Oliveira Tavares, Fernanda Palhano-Fontes, Patrícia Cavalcanti-Ribeiro, Victor Rocha Nóbrega de Almeida, David Cavalcante Barbosa, Tatiane Uetti Gomes Fernandes, Eduardo Igor Torquato Cardoso, Nicole Bezerra de Medeiros Lima, Aldielyson Jorge Cavalcante de Brito et al. · 2026 · Journal of Psychiatric Research
  56. MDMA and Psilocybin-Assisted Therapy in Australia: Early Real-World Prescribing, Safety Monitoring and Regulatory Developments
    Octavian Victor Brinzei · 2026
  57. Retreat from racism: A psychedelic group experience for racial stress and trauma
    Sergio Pérez Rosal, Sonya Faber, M. Myriah MacIntyre, Monnica Williams · 2026 · Psychedelics
  58. Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial
    Stacey B. Armstrong, Adam W. Levin, Nathan D. Sepeda, Hillary Shaub, Taweh Hunter, Angela Douglas, Rafael Lancelotta, Alan K. Davis · 2026 · Communications Medicine
  59. Competencies and Ethical Governance for Psychedelic‑Assisted Therapies: A Practice‑Embedded Quality‑Improvement Framework
    Shannon Dames, Keith Williams, Allan Campbell, Wes Taylor, Marti Harder, Michelle Gagnon, Geraldine Manson, Pamela Kryskow · 2026 · Journal of Evaluation in Clinical Practice
  60. Beyond Efficacy Signals: Regulatory, Methodological, and Translational Challenges in Clinical Research on Ketamine and Psilocybin in Psychiatry
    Damian Świeczkowski, Michał Pruc, Łukasz Szarpak, Aleksander Kwaśny, Wiesław Jerzy Cubała · 2026 · Psychiatry International
  61. Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders
    Kathryn Fletcher, Jack Freestone, Nadine Ezard, Elizabeth Knock, Krista J. Siefried · 2026 · Current Addiction Reports
  62. Designing the future of consciousness: A components framework and speculative implications
    Anatolii Belousov, Joseph Macey, Mila Bujić, Terho Ojell-Järventausta, Juho Hamari · 2026 · International Journal of Human-Computer Studies
  63. Ketamine-Assisted Intensive Short-Term Dynamic Psychotherapy
    Allen Kalpin · 2026 · Psychoanalytic Inquiry
  64. Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review
    Serena Chiara Civardi, Filippo Besana, Federico Durbano, Marco Otto Maria Toscano, F. Raffone, Bernardo Maria Dell’Osso, Miriam Olivola · 2026 · Frontiers in Psychiatry
  65. PAT-Sim: An Ethical Serious Game for Experiential Training in Psychedelic-Assisted Psychotherapy
    Tyler Reeds, Ishaan Kishore, Omid Fanaei, Rachel Marinic, Ivan Ho, Argyrios Perivolaris, Bill Kapralos, Allen Kalpin, David Chandross · 2026 · International Conference on Information, Intelligence, Systems & Applications (IISA)
  66. Epistemic Discipline in Psychedelic-Assisted Therapy: Memory, Therapy Dynamics, Attachment Patterns, and Sexual Abuse
    Guy Simon, James W. Hopper, Aaron D. Cherniak, Esenia K. Cassidy, Michael Skragge, Pehr Granqvist · 2026 · Neuroethics
  67. Building the bridge-back: Dissociation as resource and resilience pathway in psychedelic-assisted therapy
    Shannon Dames · 2026 · Journal of Psychedelic Studies
  68. Beyond the substance: A systematic review of psychological treatment frameworks in psychedelic-assisted therapy
    Gianluca Andri Florineth, Anna L. Boeker, Felix Müller, Tobias Bracht, Niklaus Denier, Antonia C. Jung, Alexander Wopfner, Kristina Adorjan, Leila Maria Soravia · 2026 · Therapeutic Advances in Psychopharmacology
  69. Participant experiences and recommendations for psychedelic clinical trials and future treatment delivery: a qualitative study with experts by experience from the Psychedelic Participant Advocacy Network
    Mathieu Seynaeve, Leonie Schneider, Ian Roullier, Katharine Lazenby, Caroline Lilley, Sophia Lobo, Anna O. Ermakova, Hattie Wells, Anthony James Cleare, James Rucker · 2026 · Frontiers in Psychiatry
  70. Ibogaine for Substance Use Disorders
    Ahmed I Anwar, Abdul-rahman A. Hegazi, M. Farris Sawaya, Joshua R. Nelson, Audrey E. Lashley, Jillian M. Gatti, Kristy M Pham, Ibraheem A. Hachem, Molly E. McNulty, Destiny S. Lewis et al. · 2026 · Advances in Therapy
  71. Clarifying “Psychotherapy” and “Psychological Support” in Psychedelic Clinical Trials: The What, the Why and the How
    William Jinwoong Choi · 2026 · Neuroethics